USV Pvt Ltd | Pioneering Excellence in Pharma & Biomedical Solution

Biosimilars

Breakthroughs in Biosimilars Through Dynamic R&D

overview

infrastructure & capabilities

Overview

Science Behind Biosimilars

At USV, we believe that science-driven research is the key to developing high-quality, affordable biotherapeutics. Our biologics team excels in developing biosimilars, from cloning to commercial-scale manufacturing, ensuring coverage of all aspects of development, including establishing similarity in terms of quality, safety, and efficacy with the capability to register products in regulated markets.

Infrastructure & Capabilities

Biosimilar Capabilities

Our facilities are equipped with advanced analytical and characterisation instruments, including Sciex ZenoTOF 7600, a high-resolution mass spectrometer for in-depth molecular characterisation. Our R&D labs are fully integrated to develop high-quality biosimilars for the regulated and ROW markets. Our research capabilities include molecular biology, microbiology, protein chemistry, bio-immunoassay, and analytical development across therapy areas such as immunology and oncology. Our diverse pipeline includes microbial and mammalian biosimilars, like insulin analogues and monoclonal antibodies, at various development stages.